Immune Checkpoint Inhibitor Treatment and Ophthalmologist Consultations in Patients with Malignant Melanoma or Lung Cancer-A Nationwide Cohort Study.

Maria D'SouzaMette BaggerMark AlbertiMorten MalmborgMorten SchouChristian Torp-PedersenGunnar GislasonInge Marie Svane Jens Folke Kiilgaard

Published in: Cancers (2021)

The one-year risks of first-time ophthalmologist consultation and ocular inflammation were 6% and 1%, respectively, in patients treated with ICI. In patients with LC and MM, the risk was increased in patients with ICI compared with patients without ICI.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
palliative care
peritoneal dialysis
prognostic factors
mass spectrometry
human health
high resolution
combination therapy
general practice